Early Prognostic Factors for the Progress of Preeclampsia – Our Experience in the Period 2010-2011
DOI:
https://doi.org/10.3889/oamjms.2016.065Keywords:
Preeclampsia, Doppler test, Pregnancy-associated plasma protein A, Body Mass IndexAbstract
AIM: To determine the prognostic value of the low Pregnancy-associated plasma protein A (PAPP-A) levels in the early stages of pregnancy (11–13 weeks GA) independently and in combination with a Doppler test of the uterine arteries during the second half of pregnancy (22–23 weeks GA).
MATERIAL AND METHODS: The study covered the period 2010–2011 and included 106 pregnant women, aged 35–40, with a single child pregnancy. The research excluded pregnant women with anomalies of the fetus, smokers and women taking prophylactically low doses of aspirin.
RESULTS: Thirty-six pregnant women had PAPP-A level below 0.4 MoM, whereas 20 of them developed preeclampsia and 7 – early preeclampsia. The combination of the low PAPP-A values and the abnormal Doppler test of the uterine arteries is with a considerably better prognostic value in regards to the risk of developing preeclampsia.
CONCLUSION: The Doppler test is a non-invasive, quick and easy method for assessment of the uterine-placental blood flow.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Roberts JM, Gammill HS. Preeclampsia: Recent insights. Hypertension. 2005;46:1243–1249. http://dx.doi.org/10.1161/01.HYP.0000188408.49896.c5 PMid:16230510
Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016;27(2):71-8. http://dx.doi.org/10.5830/CVJA-2016-009 PMid:27213853 PMCid:PMC4928171
Khong SL, Kane SC, Brennecke SP, da Silva Costa F. First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications. Dis Markers. 2015;2015:679730. http://dx.doi.org/10.1155/2015/679730 PMid:25972623 PMCid:PMC4418013
Deveci K, Sogut E, Evliyaoglu O, Duras N. Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester. J Obstet Gynaecol Res. 2009;35:94–98. http://dx.doi.org/10.1111/j.1447-0756.2008.00835.x PMid:19215554
Bersinger NA, Odegard RA. Second- and third-trimester serum levels of placental proteins in pre-eclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand. 2004;83:37–45. http://dx.doi.org/10.1111/j.1600-0412.2004.00277.x
Bersinger NA, Smarason AK, Muttukrishna S, Groome NP, Redman CW. Women with pre-eclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin-A, activin-A and soluble E-selectin. Hypertens Pregnancy. 2003;22:45–55. http://dx.doi.org/10.1081/PRG-120016794 PMid:12648442
Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, pre-eclampsia, and stillbirth. J Clin Endocrinol Metab. 2002;87:1762–1767. http://dx.doi.org/10.1210/jcem.87.4.8430 PMid:11932314
Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M. Placental growth factor and soluble fms-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol 2007;109:1368–74. http://dx.doi.org/10.1097/01.AOG.0000264552.85436.a1 PMid:17540809
Chaiworapongsa T, Romero R, Tarca A, Kusanovic JP, Mittal P, Kim SK, Gotsch F, et al. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: Evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med. 2009;22:1122–1139. http://dx.doi.org/10.3109/14767050902994838 PMid:19916710 PMCid:PMC3437777
Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigó J Jr. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res. 2010;33:892–898. http://dx.doi.org/10.1038/hr.2010.92 PMid:20535121
Mijal RS, Holzman CB, Rana S, Karumanchi SA, Wang J, Sikorskii A. Midpregnancy levels of angiogenic markers in relation to maternal characteristics. Am J Obstet Gynecol. 2011;204:244.e1–244.12.
Wu P, van den Berg C, Alfirevic Z, O'Brien S, Röthlisberger M, Baker PN, Kenny LC, Kublickiene K, Duvekot JJ. Early pregnancy biomarkers in pre-eclampsia: a systematic review and meta-analysis. International journal of molecular sciences. 2015 Sep 23;16(9):23035-56. http://dx.doi.org/10.3390/ijms160923035 PMid:26404264 PMCid:PMC4613350
Condeâ€Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for predicting intrauterine growth restriction: a systematic review and metaâ€analysis. BJOG: An International Journal of Obstetrics & Gynaecology. 2013 May 1;120(6):681-94. http://dx.doi.org/10.1111/1471-0528.12172 PMid:23398929
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
